State MI
Clinical Trials in Michigan
Michigan is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Michigan and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 319 actively recruiting studies with Michigan sites out of 319 registered in total. The busiest research areas in Michigan are Prostate Cancer, Advanced Solid Tumor, Solid Tumors. Leading sponsors running trials in the state include University of Michigan, University of Michigan Rogel Cancer Center, National Cancer Institute (NCI). By stage, Michigan trials break down as Phase 1 (57), Phase 2 (97), Phase 3 (88), Phase 4 (10).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Michigan
Frequently Asked Questions — Clinical Trials in Michigan
How many clinical trials are currently recruiting in Michigan?
ClinicalMetric currently tracks 319 actively recruiting clinical trials with at least one location in Michigan. The total number of registered studies—including active but not currently enrolling trials—is 319. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Michigan?
Michigan hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Advanced Solid Tumor, Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Michigan serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Michigan?
To join a clinical trial in Michigan, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Michigan maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Michigan
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
NCT07095114 N/A
Recruiting
A Study of Disappearing Markers for Daily Radiation Treatment Delivery for Breas...
Condition
Ductal Carcinoma in Situ
Enrollment
30 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In
NCT06439914 Phase 1
Recruiting
First-in-human Study of Interferon-y PET Imaging to Assess Response to Immunothe...
Condition
Non Small Cell Lung Cancer
Enrollment
6 pts
Location
United States
Sponsor
Nerissa T. Viola
NCT06080789 Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Part...
Condition
Acute Pancreatitis
Enrollment
36 pts
Location
United States, India
Sponsor
Panafina, Inc.
NCT04792489 Phase 2
Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
Condition
Refractory Diffuse Large B Cell Lymphoma (DLBCL)
Enrollment
315 pts
Location
United States, Canada
Sponsor
Miltenyi Biomedicine GmbH
NCT03178149 Phase 1
Recruiting
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losin...
Condition
Age-Related Macular Degeneration
Enrollment
42 pts
Location
United States
Sponsor
Astellas Institute for Regener
NCT04614103 Phase 2
Recruiting
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
Condition
Metastatic Non Small Cell Lung Cancer
Enrollment
170 pts
Location
United States, Australia, Canada
Sponsor
Iovance Biotherapeutics, Inc.
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
NCT07082738 Phase 2
Recruiting
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Ve...
Condition
Chronic Obstructive Pulmonary Disease (COPD)
Enrollment
987 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07828704 Phase 2
Recruiting
Photodynamic Diagnosis of Kidney Cancer Using Fluorescence Endoscopy and Oral 5-...
Condition
Kidney Cancers
Enrollment
10 pts
Location
United States
Sponsor
Henry Ford Health System
NCT06750094 Phase 3
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in P...
Condition
Colorectal Neoplasms
Enrollment
700 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
NCT03850366 Phase 2
Recruiting
HLA-Haploidentical Peripheral Blood Stem Cell Transplantation With Post-transpla...
Condition
Hematological Malignancy
Enrollment
15 pts
Location
United States
Sponsor
Henry Ford Health System
NCT05137054 Phase 1
Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination Wit...
Condition
Multiple Myeloma
Enrollment
317 pts
Location
United States, France, Greece
Sponsor
Regeneron Pharmaceuticals
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradioth...
Condition
Urothelial Cancer
Enrollment
390 pts
Location
United States, Canada, South Korea
Sponsor
Astellas Pharma Global Develop
NCT07047144 Phase 2
Recruiting
A Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years ...
Condition
Spinal Muscular Atrophy
Enrollment
52 pts
Location
United States, Belgium, France
Sponsor
Scholar Rock, Inc.
NCT07151677 N/A
Recruiting
Brain Stimulation Effects on Post-Stroke Fatigue and Aphasia
Condition
Aphasia Following Cerebral Infarction
Enrollment
60 pts
Location
United States
Sponsor
Syracuse University
NCT06252649 Phase 3
Recruiting
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevac...
Condition
Metastatic Colorectal Cancer
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT07144150 N/A
Recruiting
EVERO Drug-coated Balloon (DCB) Randomized Trial
Condition
Peripheral Vascular Disease
Enrollment
410 pts
Location
United States
Sponsor
Cook Research Incorporated
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT06957366 N/A
Recruiting
Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patien...
Condition
Atrial Fibrillation (AF)
Enrollment
920 pts
Location
United States, Belgium, Canada
Sponsor
McMaster University
NCT05956041 Phase 2
Recruiting
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous...
Condition
Cutaneous T Cell Lymphoma
Enrollment
23 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT07630974 Phase 1, Phase 2
Recruiting
A Study of Ifinatamab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
134 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT05965180 N/A
Recruiting
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using ...
Condition
Prostate Cancer
Enrollment
50 pts
Location
United States
Sponsor
University of Michigan Rogel C
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology